Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Abrams

Showing results (331-340 of 371) with videos related to

Pageof 38
Sort By:
Cancer Immunology, Immunotherapy : CII|February 15, 2022
VSSP abrogates murine ovarian tumor-associated myeloid cell-driven immune suppression and induces M1 polarization in tumor-associated macrophages from ovarian cancer patientsAnm Nazmul H Khan, Tiffany R Emmons, William J Magner, et al.
AIDS (London, England)|March 28, 1998
A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals. Terry Beirn Community Programs for Clinical Research on AIDSC L Brosgart, T A Louis, D W Hillman, et al.
Oncotarget|April 19, 2015
Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancerAnm Nazmul H Khan, Nonna Kolomeyevskaya, Kelly L Singel, et al.
Journal for Immunotherapy of Cancer|December 4, 2021
Immunization with short peptide particles reveals a functional CD8<sup>+</sup> T-cell neoepitope in a murine renal carcinoma modelXuedan He, Shiqi Zhou, Melissa Dolan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 1, 2023
Tristetraprolin regulates the skeletal phenotype and osteoclastogenic potential through monocytic myeloid-derived suppressor cellsLixia Zhang, Kyu Hwan Kwack, Ramkumar Thiyagarajan, et al.
AIDS (London, England)|July 14, 2000
A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDSJ D Baxter, D L Mayers, D N Wentworth, et al.
Breast Cancer Research : BCR|October 28, 2018
Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growthSerena P H Mao, Minji Park, Ramon M Cabrera, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2015
IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiationAmy V Paschall, Ruihua Zhang, Chen-Feng Qi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 1, 2025
BiTE-secreting T cells rationally combine with PD-1 blockade and vaccine boosting to reshape antitumor immunity in ovarian cancerJessie L Chiello, Nijamuddin Shaikh, Justine Jacobi, et al.
The Journal of Clinical Investigation|December 1, 2022
Inhibiting the biogenesis of myeloid-derived suppressor cells enhances immunotherapy efficacy against mammary tumor progressionSean H Colligan, Andrea M Amitrano, Robert A Zollo, et al.
Pageof 38

Showing results (331-340 of 371) with videos related to

Sort By:
Pageof 38
Cancer Immunology, Immunotherapy : CII|February 15, 2022
VSSP abrogates murine ovarian tumor-associated myeloid cell-driven immune suppression and induces M1 polarization in tumor-associated macrophages from ovarian cancer patientsAnm Nazmul H Khan, Tiffany R Emmons, William J Magner, et al.
AIDS (London, England)|March 28, 1998
A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals. Terry Beirn Community Programs for Clinical Research on AIDSC L Brosgart, T A Louis, D W Hillman, et al.
Oncotarget|April 19, 2015
Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancerAnm Nazmul H Khan, Nonna Kolomeyevskaya, Kelly L Singel, et al.
Journal for Immunotherapy of Cancer|December 4, 2021
Immunization with short peptide particles reveals a functional CD8<sup>+</sup> T-cell neoepitope in a murine renal carcinoma modelXuedan He, Shiqi Zhou, Melissa Dolan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 1, 2023
Tristetraprolin regulates the skeletal phenotype and osteoclastogenic potential through monocytic myeloid-derived suppressor cellsLixia Zhang, Kyu Hwan Kwack, Ramkumar Thiyagarajan, et al.
AIDS (London, England)|July 14, 2000
A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDSJ D Baxter, D L Mayers, D N Wentworth, et al.
Breast Cancer Research : BCR|October 28, 2018
Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growthSerena P H Mao, Minji Park, Ramon M Cabrera, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2015
IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiationAmy V Paschall, Ruihua Zhang, Chen-Feng Qi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 1, 2025
BiTE-secreting T cells rationally combine with PD-1 blockade and vaccine boosting to reshape antitumor immunity in ovarian cancerJessie L Chiello, Nijamuddin Shaikh, Justine Jacobi, et al.
The Journal of Clinical Investigation|December 1, 2022
Inhibiting the biogenesis of myeloid-derived suppressor cells enhances immunotherapy efficacy against mammary tumor progressionSean H Colligan, Andrea M Amitrano, Robert A Zollo, et al.
Pageof 38